Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Is Moderna Stock Outperforming the S&P 500?

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a pioneering biotechnology company and a global leader in mRNA therapeutics and vaccines. With a market cap of $51.07 billion, Moderna has revolutionized the pharmaceutical industry by leveraging its innovative mRNA technology to develop treatments for a wide range of diseases. As a major player in the biotech industry, Moderna competes fiercely with companies like Pfizer Inc. (PFE), which is known for its extensive pharmaceutical and vaccine portfolios.

Companies valued at $10 billion or more are generally considered "large-caps," and Moderna fits this criterion perfectly, signifying its substantial size, stability, and influence in the biotechnology industry. Renowned for its groundbreaking mRNA technology and swift development of the COVID-19 vaccine, MRNA is at the forefront of biopharmaceutical innovation. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.